LncRNA AFAP1-AS1 Promotes Oral Squamous Cell Carcinoma Development by Ubiquitin-Mediated Proteolysis
International Dental Journal · 2024
DOI: 10.1016/j.identj.2024.04.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Dental Journal, 2024. Verfasst von Bao-Jun Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Mouth Neoplasms, Carcinoma, Squamous Cell, Ubiquitin. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Harbin Medical University.
Abstract (Originalsprache)
BACKGROUND AND PURPOSE: Long noncoding RNA (lncRNA) dysregulation has been reported to play a pivotal role in the development of cancers. In this study, we aimed to screen the key lncRNA in oral squamous cell carcinoma (OSCC) via bioinformatics analysis and further validate the function of lncRNA in vitro and in vivo. METHODS: Bioinformatics analysis was conducted to identify differentially expressed lncRNAs between control and OSCC samples. Quantitative real-time-polymerase chain reaction was employed to detect the expression of differentially expressed lncRNAs in human tongue squamous cell carcinoma and human oral keratinocytes cell lines. The biological function of lncRNA and its mechanism were examined via the experimental assessment of the cell lines with the lncRNA overexpressed and silenced. Additionally, to further explore the function of lncRNA in the progression of OSCC, xenograft tumour mouse models were established using 25 mice (5 groups, each with 5 mice). Tumour formation was observed at 2 weeks after the cell injection, and the tumours were resected at 5 weeks post-implantation. RESULTS: Two lncRNAs, LINC00958 and AFAP1-AS1, were found to be correlated with the prognosis of OSCC. The results of the quantitative real-time-polymerase chain reaction indicated that the 2 lncRNAs were highly expressed in OSCC. In combination with the previous literature, we found AFAP1-AS1 to be a potentially important biomarker for OSCC. Thus, we further investigated its biological function and found that AFAP1-AS1 silencing inhibited cell proliferation, migration, and invasion whereas AFAP1-AS1 overexpression reversed the effect of AFAP1-AS1 silencing (P < .05). Mechanism analysis revealed that AFAP1-AS1 regulated the development of OSCC through the ubiquitin-mediated proteolysis pathway. CONCLUSIONS: AFAP1-AS1 is an oncogene that aggravates the development of OSCC via the ubiquitin-mediated proteolysis pathway. It also provides a novel potential therapy for OSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
- Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
- Department of Medical Ultrasound, Harbin Medical University Cancer Hospital, Harbin, China.
- Department of Oral and Maxillofacial Surgery, The First Affiliate Hospital of Harbin Medical University, Harbin, China.
- Department of Oral and Maxillofacial Surgery, The First Affiliate Hospital of Harbin Medical University, Harbin, China. Electronic address: jiaoxiaohui_doctor@163.com.
Förderung
- Harbin Medical University
Zitieren
APA
Li, B. J., Ren, F. H., Zhang, C., Zhang, X. W., & Jiao, X. H. (2024). LncRNA AFAP1-AS1 Promotes Oral Squamous Cell Carcinoma Development by Ubiquitin-Mediated Proteolysis. International Dental Journal. https://doi.org/10.1016/j.identj.2024.04.024
Vancouver
Li BJ, Ren FH, Zhang C, Zhang XW, Jiao XH. LncRNA AFAP1-AS1 Promotes Oral Squamous Cell Carcinoma Development by Ubiquitin-Mediated Proteolysis. International Dental Journal. 2024. doi:10.1016/j.identj.2024.04.024
BibTeX
@article{Li2024,
author = {Li, Bao-Jun and Ren, Feng-Hai and Zhang, Cui and Zhang, Xing-Wei and Jiao, Xiao-Hui},
title = {LncRNA AFAP1-AS1 Promotes Oral Squamous Cell Carcinoma Development by Ubiquitin-Mediated Proteolysis},
journal = {International Dental Journal},
year = {2024},
doi = {10.1016/j.identj.2024.04.024}
}
EUVIMED